Claus Hanusch
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 53
- Cancer Genomics and Diagnostics 13
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 32
- HER2/EGFR in Cancer Research 26
- Cancer Immunotherapy and Biomarkers 13
-
- Breast Lesions and Carcinomas 15
- Immunology top 5%
-
- Advanced Breast Cancer Therapies 21
-
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Sibylle LoiblGϋnter von MinckwitzCarsten DenkertChristian JackischJens HuoberJens‐Uwe BlohmerMichael UntchHolger Eidtmann
- Journals
- Journal of Clinical Oncology (27 papers)Annals of Oncology (20 papers)Cancer Research (11 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Claus Hanusch
81 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 2.2k
- Oncology 3.3k
- Pathology and Forensic Medicine 640
- Immunology 741
- Radiology, Nuclear Medicine and Imaging 622
Countries citing papers authored by Claus Hanusch
This map shows the geographic impact of Claus Hanusch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus Hanusch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus Hanusch more than expected).
Fields of papers citing papers by Claus Hanusch
This network shows the impact of papers produced by Claus Hanusch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus Hanusch. The network helps show where Claus Hanusch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claus Hanusch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 2 | |
| 5 | Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete responsebreakdown → | 2022 | 136 |
| 6 | 2021 | 2 | |
| 7 | 2021 | 5 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 3 | |
| 10 | 2020 | 2 | |
| 11 | 2019 | 4 | |
| 12 | 2018 | 40 | |
| 13 | 2017 | 17 | |
| 14 | 2016 | 3 | |
| 15 | 2014 | 16 | |
| 16 | 2013 | 265 | |
| 17 | 2013 | 51 | |
| 18 | 2013 | 105 | |
| 19 | 2012 | 297 | |
| 20 | 2008 | 182 |
About Claus Hanusch
Claus Hanusch is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 81 papers that have together received 4.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (53 papers), Cancer Treatment and Pharmacology (32 papers), HER2/EGFR in Cancer Research (26 papers), Advanced Breast Cancer Therapies (21 papers), Breast Lesions and Carcinomas (15 papers), Cancer Immunotherapy and Biomarkers (13 papers), Cancer Genomics and Diagnostics (13 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (3.3k citations) and Pathology and Forensic Medicine (640 citations). Claus Hanusch has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Sibylle Loibl, Gϋnter von Minckwitz, Carsten Denkert, Christian Jackisch, Jens Huober, Jens‐Uwe Blohmer, Michael Untch, Holger Eidtmann, Christine Solbach and J. Hilfrich. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, European Journal of Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.